These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Significant increase of succinylacetone within the first 12 h of life in hereditary tyrosinemia type 1.
    Author: Schlump JU, Mayatepek E, Spiekerkoetter U.
    Journal: Eur J Pediatr; 2010 May; 169(5):569-72. PubMed ID: 19813022.
    Abstract:
    INTRODUCTION: In most countries, hereditary tyrosinemia type 1 is not included in routine newborn screening. DISCUSSION: We present the case of a female newborn with prenatal diagnosis of hereditary tyrosinemia type 1 and clear identification of this disorder by succinylacetone measurement in cord blood and peripheral blood immediately after birth. Succinylacetone was 44 micromol/L (norm <5 micromol/L) and increased within 12 h to 87.5 micromol/L. CONCLUSION: With the high toxic potential of downstream metabolites, these data clearly point out the necessity of early nitisinone treatment to prevent symptomatic disease.
    [Abstract] [Full Text] [Related] [New Search]